[Analysis of clinical characteristics and influencing factors of patients with postmenopausal osteoporosis combined with dyslipidemia].
Focus should be placed on the influencing factors of PMOP and dyslipidemia co-morbidities, with emphasis on multidimensional assessment, combining lifestyle interventions with bone metabolism marker monitoring to optimize co-morbidity management.
Authors
- Tian-Xiao Feng
- Ling‐Hui Li (ORCID: https://orcid.org/0000-0003-1302-4215)
- Ke Zhao (ORCID: https://orcid.org/0000-0003-0179-6883)
- Rong Xie (ORCID: https://orcid.org/0009-0004-1559-2464)
- Zikai Jin
- Wang Da (ORCID: https://orcid.org/0000-0002-1241-8506)
- Xu Wei (ORCID: https://orcid.org/0000-0002-2395-2608)
- Liguo Zhu (ORCID: https://orcid.org/0000-0002-1931-8647)
Institutions
- Beijing University of Chinese Medicine (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-25
- DOI
- https://doi.org/10.12200/j.issn.1003-0034.20250217
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article